Technical Analysis for CYTX - Cytori Therapeutics Inc

Grade Last Price % Change Price Change
grade F 0.2404 0.17% 0.00
CYTX closed up 0.17 percent on Monday, May 20, 2019, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CYTX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.17%
NR7 Range Contraction 0.17%
Earnings Movers Other 0.17%
Wide Bands Range Expansion 0.17%

Older signals for CYTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Cytori Therapeutics, Inc., a cell therapy company, engages in developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular diseases and other medical conditions. It primarily provides the Celution System, which automates the process of digesting fat tissue, releasing the ADRCs. It also offers the StemSource Cell Bank, a suite of products to allow hospitals or tissue banks to cryopreserve adipose-derived stem and regenerative cells; and StemSource 900/MB, a research laboratory equipment, as well as a range of ancillary products designed to optimize tissue harvest and graft delivery. Its products also include Celution 800 System that has CE Mark approval for certain soft tissue procedures, such as breast reconstruction, tissue ischemia, deficiency or injury of skin, fat, and muscle and fascia, as well as soft tissue wounds or fistulae associated with trauma, diabetes, ischemia, and radiation injury. The company markets its systems, instrumentations, and consumables directly, as well as through a network of distributors to hospitals, plastic surgery clinics, tissue banks, and stem cell banking companies, as well as researchers performing investigator-initiated and funded studies worldwide. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.
Biotechnology Biology Diabetes Nature Stem Cells Radiation Cell Biology Ancillary Products Cardiovascular Diseases Cell Therapy Injury Plastic Surgery Stem Cell Therapy Connective Tissue Deficiency Amniotic Stem Cell Bank Breast Reconstruction Ingeneron Radiation Injury
Is CYTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.0
52 Week Low 0.22
Average Volume 663,995
200-Day Moving Average 0.3447
50-Day Moving Average 0.2809
20-Day Moving Average 0.2771
10-Day Moving Average 0.2572
Average True Range 0.028
ADX 18.71
+DI 11.3241
-DI 17.9192
Chandelier Exit (Long, 3 ATRs ) 0.256
Chandelier Exit (Short, 3 ATRs ) 0.324
Upper Bollinger Band 0.3264
Lower Bollinger Band 0.2278
Percent B (%b) 0.13
BandWidth 35.582822
MACD Line -0.0136
MACD Signal Line -0.009
MACD Histogram -0.0046
Fundamentals Value
Market Cap 8.35 Million
Num Shares 34.7 Million
EPS -1.00
Price-to-Earnings (P/E) Ratio -0.24
Price-to-Sales 1.71
Price-to-Book 1.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.25
Resistance 3 (R3) 0.25 0.24 0.24
Resistance 2 (R2) 0.24 0.24 0.24 0.24
Resistance 1 (R1) 0.24 0.24 0.24 0.24 0.24
Pivot Point 0.24 0.24 0.24 0.24 0.24
Support 1 (S1) 0.24 0.24 0.24 0.24 0.24
Support 2 (S2) 0.24 0.24 0.24 0.24
Support 3 (S3) 0.24 0.24 0.24
Support 4 (S4) 0.24